Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma
Clinical trial NCT05448885 · UNKNOWN
Trial details
- NCT number
- NCT05448885
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2025-09-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.